Although in our study only neuronal BDNF was reduced, previous in vivo studies have reported that heterozygous BDNF;APP/PS1 mice display no alteration in amyloid plaque formation at 9 months of age (Rantamäki et al., 2013). This evidence concerns the gene BDNF and amyloidosis.